mdlinx mdlinx

A series of patients on anti-TNF therapy referred to a multidisciplinary lung cancer service Irish Journal of Medical Science, 05/01/2012

O’Connell C et al. – The series highlights the potential malignant risk of anti–TNF theraphy to a general medical audience.

Methods
  • Retrospective review of patients over an 18–month period who were referred to a multidisciplinary lung cancer service.

Results
  • Three patients who underwent recent anti–TNF therapies and presented with solid organ tumours.
  • All had significant additional risks for cancer including smoking and family history and active connective tissue diseases with a past history of immunosuppressive therapies.

Read this article on Irish Journal of Medical Science



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close